 Most data on hypertrophic cardiomyopathy related morbidity and mortality are derived primarily from longitudinal, observational studies based at tertiary cardiac centres. It is unclear what the main causes of morbidity and death are in the general hypertropic cardiomyopathy population outside tertiary referral centres and it is likely that many patients have a benign clinical course and die from non-cardiac causes. 